Published in Cancer Res on November 15, 1996
The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem Cell Biol (2001) 3.31
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol (1999) 2.17
Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J (2005) 1.85
The family feud: turning off Sp1 by Sp1-like KLF proteins. Biochem J (2005) 1.83
Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res (2008) 1.36
Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression. Oncogene (2008) 1.08
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer (2002) 1.08
Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells. Cancer Res (2009) 1.08
Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol Cell Biol (2002) 1.04
Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting. Br J Pharmacol (2006) 1.04
DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells. Mol Endocrinol (2010) 0.99
Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II. Cancer Res (2008) 0.96
Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res (2010) 0.90
Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells. PLoS One (2013) 0.89
PTHrP is a novel mediator for TGF-β-induced apoptosis. Regul Pept (2013) 0.80
Mesoderm induction in amphibians: the role of TGF-beta 2-like factors. Science (1988) 2.68
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (1991) 2.37
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol (2000) 2.17
Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest (1989) 2.16
A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol (1998) 1.94
Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest (1993) 1.78
Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis. Cell Regul (1989) 1.61
Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis (2013) 1.58
Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J Biol Chem (2000) 1.55
A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas. Cancer Res (1993) 1.55
Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis. Crit Care Med (1999) 1.53
Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol (1991) 1.52
Differential function of intestinal intraepithelial lymphocyte subsets. J Immunol (1992) 1.51
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer (1990) 1.48
A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J Biol Chem (1999) 1.46
Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene (2006) 1.45
Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest (2000) 1.44
Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol (2001) 1.40
Increased midkine gene expression in human gastrointestinal cancers. Jpn J Cancer Res (1995) 1.39
Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest (2000) 1.37
Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol (1994) 1.36
Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer (2000) 1.34
Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem (1991) 1.34
Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci U S A (2000) 1.32
Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta. Cell Regul (1991) 1.27
Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J Biol Chem (2001) 1.26
Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res (1995) 1.26
The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. Prostate (1999) 1.25
Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Cancer Res (1999) 1.24
Abnormalities of sensory and memory functions in mice lacking Bsg gene. Biochem Biophys Res Commun (1997) 1.22
Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells. Cancer Res (2001) 1.22
Expression of basigin, a member of the immunoglobulin superfamily, in the mouse central nervous system. Neurosci Res (1998) 1.20
Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells (1998) 1.20
Increased expression of midkine during the progression of human astrocytomas. Neurosci Lett (1997) 1.18
A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem (1990) 1.18
Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. J Biol Chem (2001) 1.17
Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine. J Biochem (2000) 1.17
Localization of transforming growth factor-beta 1 in mitochondria of murine heart and liver. Cell Regul (1991) 1.17
Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res (1994) 1.17
Retinal dysfunction in basigin deficiency. Invest Ophthalmol Vis Sci (2000) 1.13
Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett (1998) 1.12
The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activity. Cell Death Dis (2010) 1.11
Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res (1994) 1.10
Immunohistochemical analysis of midkine expression in human prostate carcinoma. Oncology (1999) 1.10
Homo-oligomer formation by basigin, an immunoglobulin superfamily member, via its N-terminal immunoglobulin domain. Eur J Biochem (2000) 1.09
Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer (1999) 1.09
Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression. Oncogene (2008) 1.08
Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase. J Biol Chem (1998) 1.08
Functional modules and expression of mouse p40(phox) and p67(phox), SH3-domain-containing proteins involved in the phagocyte NADPH oxidase complex. Eur J Biochem (1998) 1.08
Roles of basigin, a member of the immunoglobulin superfamily, in behavior as to an irritating odor, lymphocyte response, and blood-brain barrier. Biochem Biophys Res Commun (1996) 1.07
Multiple forms of TGF-beta: distinct promoters and differential expression. Ciba Found Symp (1991) 1.07
Behaviour of a sperm surface transmembrane glycoprotein basigin during epididymal maturation and its role in fertilization in mice. Reproduction (2002) 1.07
Severity of acute pancreatitis: a multivariate analysis of oxidative stress markers and modified Glasgow criteria. Br J Surg (2000) 1.05
Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells. J Biol Chem (2001) 1.04
A retinoic acid responsive gene, MK, produces a secreted protein with heparin binding activity. Biochem Biophys Res Commun (1990) 1.03
Human N-acetylglucosamine-6-O-sulfotransferase involved in the biosynthesis of 6-sulfo sialyl Lewis X: molecular cloning, chromosomal mapping, and expression in various organs and tumor cells. J Biochem (1998) 1.02
Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55. Oncogene (2008) 1.00
Transforming growth factor-beta in calf articular cartilage organ cultures: synthesis and distribution. Arch Biochem Biophys (1991) 1.00
Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization. Cell Death Differ (2009) 0.99
Radiation-induced lung injury in vivo: expression of transforming growth factor-beta precedes fibrosis. Inflammation (1996) 0.99
The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. J Clin Invest (1991) 0.98
Retinal degeneration following failed photoreceptor maturation in 5A11/basigin null mice. Exp Eye Res (2001) 0.98
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. Proc Natl Acad Sci U S A (1992) 0.98
Antibodies to transforming growth factor-beta 2 peptides: specific detection of TGF-beta 2 in immunoassays. Growth Factors (1990) 0.98
The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. J Cell Physiol (1998) 0.96
Aberrant TGF-beta production and regulation in metastatic malignancy. Growth Factors (1990) 0.96
Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem (1997) 0.96
Syndecan-4 deficiency impairs the fetal vessels in the placental labyrinth. Dev Dyn (2000) 0.95
Expression of midkine and pleiotropin in ovarian tumors. Obstet Gynecol (1997) 0.95
Splanchnic mucosal ischemia: an unrecognized consequence of routine pneumoperitoneum. Surg Laparosc Endosc (1997) 0.95
ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells. Oncogene (2006) 0.95
Histological characterization of defective spermatogenesis in mice lacking the basigin gene. Anat Histol Embryol (1999) 0.94
A new family of heparin-binding factors: strong conservation of midkine (MK) sequences between the human and the mouse. Biochem Biophys Res Commun (1991) 0.94
Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol (1990) 0.94
Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res (1994) 0.93
Embigin/basigin subgroup of the immunoglobulin superfamily: different modes of expression during mouse embryogenesis and correlated expression with carbohydrate antigenic markers. Dev Growth Differ (1998) 0.93
Genomic structure of human midkine (MK), a retinoic acid-responsive growth/differentiation factor. J Biochem (1992) 0.92
Syndecan-4 deficiency increases susceptibility to kappa-carrageenan-induced renal damage. Lab Invest (2001) 0.92
Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. Br J Cancer (1998) 0.92
Isolation and characterization of TGF-beta 2 and TGF-beta 5 from medium conditioned by Xenopus XTC cells. Growth Factors (1990) 0.92
Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas. Br J Cancer (2003) 0.92
Mesoderm induction in Xenopus laevis distinguishes between the various TGF-beta isoforms. Growth Factors (1990) 0.91
Embigin, a member of the immunoglobulin superfamily expressed in embryonic cells, enhances cell-substratum adhesion. Dev Biol (1993) 0.90
The expression of truncated MK in human tumors. Biochem Biophys Res Commun (1996) 0.90
Improved purification and yields of RNA by RNeasy. Biotechniques (1996) 0.89
Expression of herpes simplex virus-thymidine kinase gene controlled by a promoter region of the midkine gene confers selective cytotoxicity to ganciclovir in human carcinoma cells. Int J Cancer (2001) 0.89
Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology (2000) 0.89
Midkine promoter-driven suicide gene expression and -mediated adenovirus replication produced cytotoxic effects to immortalised and tumour cells. Eur J Cancer (2004) 0.89
Glypican-2 binds to midkine: the role of glypican-2 in neuronal cell adhesion and neurite outgrowth. Glycoconj J (2001) 0.88
Dimerization of midkine by tissue transglutaminase and its functional implication. J Biol Chem (1997) 0.88
Developmentally regulated expression of embigin, a member of the immunoglobulin superfamily found in embryonal carcinoma cells. Differentiation (1990) 0.88
Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy. Jpn J Cancer Res (1999) 0.88
Differential regulation of the expression of transforming growth factor-beta mRNAs by growth factors and retinoic acid in chicken embryo chondrocytes, myocytes, and fibroblasts. J Cell Physiol (1992) 0.87
A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter. Br J Cancer (2003) 0.87
Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther (2005) 0.86
Retinoid and androgen regulation of cell growth, epidermal growth factor and retinoic acid receptors in normal and carcinoma rat prostate cells. Mol Cell Endocrinol (1999) 0.86
Regulation of expression of transforming growth factor-beta 2 by transforming growth factor-beta isoforms is dependent upon cell type. Growth Factors (1992) 0.85
Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas. J Biochem (1996) 0.85
Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Cancer Res (1990) 0.84